Blocage de l’aldostérone : état des lieux en 2024 [The 2024 landscape of aldosterone blockade]

Details

Ressource 1Request a copy Under embargo until 11/03/2026.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_089E0E4C27D0
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Blocage de l’aldostérone : état des lieux en 2024 [The 2024 landscape of aldosterone blockade]
Journal
Revue medicale suisse
Author(s)
Zahnd J., Mehier P., Wuerzner G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
11/09/2024
Peer-reviewed
Oui
Volume
20
Number
886
Pages
1598-1601
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Aldosterone is a steroid hormone playing a key role in arterial hypertension physiopathology. In case of inappropriate secretion, it has a detrimental action on the kidney and cardiovascular system and therefore constitutes an interesting therapeutic target for several diseases. Recent progress allowed to expand the therapeutic arsenal for physician practitioner and new promising drugs will probably appear on the market the next few years. Hence, physicians should know the indications and side effects of these new treatments.
Keywords
Humans, Mineralocorticoid Receptor Antagonists/therapeutic use, Aldosterone/metabolism, Hypertension/drug therapy, Cardiovascular Diseases/drug therapy
Pubmed
Create date
17/09/2024 8:41
Last modification date
18/09/2024 6:09
Usage data